When should a loading dose be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Give a Loading Dose

Loading doses should be administered for critically ill patients requiring rapid achievement of therapeutic drug concentrations, particularly for antimicrobials with low volumes of distribution (polymyxins, beta-lactams, vancomycin) and for all patients receiving continuous infusions of beta-lactam antibiotics, regardless of renal function or severity of illness. 1

Antimicrobials Requiring Loading Doses

Polymyxins (Colistin and Polymyxin B)

  • Colistin requires a loading dose of 6-9 million IU in all patients, including those with renal dysfunction, because plasma concentrations remain suboptimal for 2-3 days before reaching steady state without a loading dose 1
  • Polymyxin B requires a loading dose of 2-2.5 mg/kg to achieve optimal plasma levels on the first day 1
  • The loading dose is mandatory regardless of renal function status 1

Beta-Lactam Antibiotics

  • All critically ill patients should receive a loading dose when starting beta-lactam therapy, independent of whether continuous or intermittent administration is planned 1
  • The loading dose should equal the standard intermittent dose (e.g., 4g piperacillin if planning 12g/24h continuous infusion) 1
  • Without a loading dose, continuous infusions may result in plasma concentrations remaining below the MIC for several hours after starting the infusion 1
  • Meta-analysis data shows mortality reduction only occurs when loading doses precede continuous infusions (RR 0.63 vs 0.56 without loading dose) 1
  • The rationale is that critically ill patients have increased volumes of distribution due to capillary permeability and fluid resuscitation, making loading doses essential even in patients with organ failure 1

Vancomycin

  • For seriously ill patients with suspected MRSA infection, administer a loading dose of 25-30 mg/kg (actual body weight) 2
  • Loading doses enable rapid achievement of therapeutic concentrations in critically ill patients with expanded extracellular volume from fluid resuscitation 2, 3
  • Loading doses are not affected by renal dysfunction and should be given regardless of kidney status 3
  • Do not give a loading dose if the patient is already receiving vancomycin therapy unless pre-existing levels are subtherapeutic in severe sepsis/septic shock 3

Teicoplanin

  • Loading dose of 25-30 mg/kg is recommended for critically ill patients to rapidly achieve therapeutic levels 4
  • For serious infections, use the higher end of the dosing range (10-12 mg/kg) for loading doses 4
  • Loading doses are not affected by alterations in renal function 4

Cardiovascular Medications

Antiarrhythmics

  • Esmolol requires a loading dose of 500 mcg/kg (0.5 mg/kg) over 1 minute before starting maintenance infusion to rapidly control heart rate in tachyarrhythmias 1
  • Amiodarone requires 150 mg over 10 minutes as a loading dose for stable narrow-complex tachycardias or pre-excited atrial arrhythmias 1
  • Digoxin requires 8-12 mcg/kg total loading dose, with half administered initially over 5 minutes 1

Antiepileptic Drugs

Phenytoin

  • Oral loading doses of 1 gram divided into three doses (400 mg, 300 mg, 300 mg) at two-hour intervals should be reserved for clinic or hospital settings with close serum level monitoring 5
  • Patients with renal or liver disease should not receive oral loading regimens 5
  • Intravenous phenytoin loading dose of 18 mg/kg infused over 20 minutes achieves therapeutic unbound concentrations within 5-20 minutes 6

Key Principles for Loading Dose Administration

Volume of Distribution Considerations

  • Loading doses are essential for drugs with low volumes of distribution in critically ill patients because these patients have expanded extracellular volumes from fluid resuscitation 1, 2, 3
  • The loading dose should be calculated based on the volume of distribution at the time of peak effect (tmax) to accurately achieve target concentrations without unexpected adverse effects 7

Renal Function Independence

  • Loading doses are not affected by renal dysfunction and should be administered at full doses even in patients with acute kidney injury or chronic kidney disease 1, 3, 4
  • Only maintenance doses require adjustment for renal function 1

Common Pitfalls to Avoid

  • Never use fixed 1-gram doses for vancomycin loading as this results in underdosing in most patients, especially those weighing >70 kg 2
  • Do not skip loading doses when initiating continuous infusions of beta-lactams, as this delays achievement of therapeutic concentrations and may contribute to treatment failure 1
  • Avoid giving loading doses to patients already on maintenance therapy unless levels are documented to be subtherapeutic 3
  • For phenytoin oral loading, never use this approach in outpatient settings or in patients with hepatic or renal disease 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vancomycin Dosing for Adult Patients with Normal Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vancomycin Dosing for Patients Undergoing SLED

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Teicoplanin Dosing in Acute Kidney Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.